Net profit of Syncom Formulations (India) rose 139.05% to Rs 17.69 crore in the quarter ended March 2025 as against Rs 7.40 crore during the previous quarter ended March 2024. Sales rose 99.65% to Rs 148.88 crore in the quarter ended March 2025 as against Rs 74.57 crore during the previous quarter ended March 2024.
For the full year,net profit rose 95.30% to Rs 49.43 crore in the year ended March 2025 as against Rs 25.31 crore during the previous year ended March 2024. Sales rose 76.55% to Rs 465.01 crore in the year ended March 2025 as against Rs 263.39 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 148.88 | 74.57 | 100 | 465.01 | 263.39 | 77 |
| OPM % | 11.92 | 12.63 | - | 11.64 | 11.25 | - |
| PBDT | 24.58 | 11.33 | 117 | 70.70 | 38.70 | 83 |
| PBT | 23.29 | 10.03 | 132 | 65.50 | 33.97 | 93 |
| NP | 17.69 | 7.40 | 139 | 49.43 | 25.31 | 95 |